Skip to content

Efficacy of the ginger saliva substitute on dry mouth in patients with radiation-induced-xerostomia: A double-blind randomized control trial

Efficacy of the ginger herbal saliva substitute on dry mouth in patients with radiation-induced-xerostomia: A double-blind randomized control trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260611006
Enrollment
40
Registered
2026-06-11
Start date
2022-06-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry mouth, xerostomia, radiation induced xerostomia, saliva substitute Dry mouth, xerostomia, radiation induced xerostomia, saliva substitute, Ginger.

Interventions

Ginger extract has shown promise in reducing xerostomia symptoms. The mechanism of action may involve ginger&#039
s parasympathetic activity and its anti-inflammatory properties. Additionally, ginger&#039
s bioactive compounds have been shown to reduce inflammation and promote vasodilation, which could contribute to improved salivary gland function,Saliva substitutes are designed to moisturize and lubr
Experimental Drug,Active Comparator Drug
Ginger saliva substitute,Standard CMC-based Saliva substitute

Sponsors

Thai Red Cross Society research funding
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Aged between 18 and 70 years and diagnosis of thyroid cancer or head and neck cancer 2. Experienced at least CTCAE grade II radiation-induced xerostomia 3. Must have all 4 xerostomia symptoms including the feeling of low amount of saliva, difficulty in swallowing food, feeling of dry mouth when eating and must sip water to help when swallowing dry food such as bread, toast, cracker or rice 4. Duration of symptoms at least 6 months prior to the study

Exclusion criteria

Exclusion criteria: 1. Known hypersensitivity to any product ingredient 2. Inability of compliance to study protocol 3. Refusal to complete the consent form

Design outcomes

Primary

MeasureTime frame
VAS score at 10 and 60 min dry mouth symptoms ,Salivary flow at 10 and 60 min Schirmer test

Secondary

MeasureTime frame
Satisfactory level after use Questionaires

Countries

Thailand

Contacts

Public ContactKanaungnit Kingpetch

Chulalongkorn University

kanaungnit.k@chula.ac.th022564000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026